FDA Roundup: December 20, 2022
FDA Roundup: December 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-20-2022
FDA Roundup: December 20, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-20-2022
Federal Court Enters Consent Decree Against Oklahoma Drug Compounder
http://www.fda.gov/news-events/press-announcements/federal-court-enters-consent-decree-against-oklahoma-drug-compounder
FDA Provides Update on External Evaluation to Strengthen Agency’s Tobacco Program
http://www.fda.gov/news-events/press-announcements/fda-provides-update-external-evaluation-strengthen-agencys-tobacco-program
http://www.fda.gov/medical-devices/medical-device-recalls/2022-medical-device-recalls
FDA Roundup: December 16, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-december-16-2022
FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer
http://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treatment-high-risk-non-muscle-invasive-bladder-cancer
Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting to Discuss Future Vaccination Regimens Addressing COVID-19
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-hold-advisory-committee-meeting-discuss-future-vaccination-regimens